Traumatic Brain Injury (TBI) Market across 21 Countries Explored by Black Swan Analysis in Its New Report Available at MarketPublishers.com
27 Oct 2016 • by Natalie Aster
LONDON - Traumatic brain injury (TBI) is a blunt, blast or penetrating injuries to the brain (focal or diffused). Focal TBI are caused by a sudden contact, for example, blow to the head; whereas diffuse TBI suggests deceleration or acceleration event, for example, motor vehicle accident.
The world TBI incidence is estimated at around 10 million people annually.
Patients suffering from TBI are under an enhanced risk of developing a range of various conditions including: mental health issues (for instance, depression, panic and generalised anxiety disorder), strokes and cerebral haemorrhage, impaired motor functionality and amnesia (retrograde and post-traumatic).
TDI therapeutics market is poised to see positive growth in the coming years, driven by rising TBI incidence owing to increasing number of military combats, assaults, accidents worldwide.
The competition in the world’s TBI therapeutics market is rather weak as this markets lacks approved therapies. This is attributed mainly to the non-specific symptoms of TBI, which prevent the diagnosis of the disease at an early stage. Meantime, due to absence of approved drugs, this sector is teeming with opportunities for novel entrants and also stalwarts of the pharma industry.
New report “Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026” by Black Swan Analysis limited covers the TDI market performance across 21 major country markets. It investigates the incident population split by 5-year age cohort and gender, includes a general overview of the disease, contains details on symptoms, risk factors, prognosis, diagnosis and ethnicity. It uncovers updated statistics on incidence figures across 21 major market, offers ten-year forecasts, provides data on the latest clinical trials, reviews the existing treatment options, offers a clear understanding of the TDI market scenario.
Other Diseases Covered in Epiomic Epidemiology Series by Black Swan Analysis:
- Prostate Cancer
- Hodgkin's Lymphoma
- Lower Back Pain and Sciatica
- Rheumatoid Arthritis
For other in-demand research reports from this publisher follow to the Black Swan Analysis catalogue.